Skip to main content
Fig. 2 | Clinical Diabetes and Endocrinology

Fig. 2

From: Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials

Fig. 2

Responders and nonresponders to insulin glargine 100 Units/mL at 24 weeks who reached blood glucose targets. Data are percentage of responders and nonresponders who reached target fasting blood glucose (≤5.6 mmol/L; ≤100 mg/dL) (a) and target postprandial glucose (≤ 180 mg/dL) after breakfast (b), lunch (c), and dinner (d). The postprandial glucose target was defined for this analysis and was not given to investigators during these trials

Back to article page

Clinical Diabetes and Endocrinology

ISSN: 2055-8260

Contact us